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Abstract  
Several evidences indicate that aging negatively affects the effectiveness of influenza 
vaccination. Although it is well established that immunosenescence has an important role in 
vaccination response, the molecular pathways underlying this process are largely unknown. 
Given the importance of epigenetic remodeling in aging, here we analyzed the relationship 
between responsiveness to influenza vaccination and DNA methylation profiles in healthy 
subjects of different ages. Peripheral blood mononuclear cells were collected from 44 subjects 
(age range: 19 – 90 years old) immediately before influenza vaccination. Subjects were 
subsequently classified as responders or non-responders according to hemagglutination 
inhibition assay 4-6 weeks after the vaccination. Baseline whole genome DNA methylation in 
peripheral blood mononuclear cells was analyzed using the Illumina® Infinium 450k 
microarray. Differential methylation analysis between the two groups (responders and non-
responders) was performed through an analysis of variance, correcting for age, sex and batch. 
We identified 83 CpG sites having a nominal p-value < 0.001 and absolute difference in DNA 
methylation of at least 0.05 between the two groups. For some CpG sites, we observed age-
dependent decrease or increase in methylation, which in some cases was specific for the 
responders and non-responders groups. Finally, we divided the cohort in two subgroups 
including younger (age < 50) and older (age ≥ 50) subjects and compared DNA methylation 
between responders and non-responders, correcting for sex and batch in each subgroup. We 
identified 142 differentially methylated CpG sites in the young subgroup and 305 in the old 
subgroup, suggesting a larger epigenetic remodeling at older ages. Interestingly, some of the 
differentially methylated probes mapped in genes involved in immunosenescence (CD40) and 
in innate immunity responses (CXCL16, ULK1, BCL11B, BTC). In conclusion, the analysis of 
epigenetic landscape can shed light on the biological basis of vaccine responsiveness during 
aging, possibly providing new appropriate biomarkers of this process.  
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1. Introduction 
Influenza is an important public health challenge in our countries, with yearly epidemics 
responsible of significant mortality, morbidity and loss of productivity (Paules and Subbarao, 
2017). Specific populations such as very young children, individuals aged 65 years and older, 
or subjects with pre-existent conditions (immunocompromised states, cardiovascular or 
cerebrovascular diseases, diabetes, chronic respiratory failure, pregnancy) are particularly 
vulnerable to this infection and at greater risk for complications.  
Vaccination is the most effective method to prevent influenza infection. Annual vaccination 
with an injectable trivalent inactivated vaccine is recommended, especially for individuals 
aged 65 years or older. However, the protection delivered by these vaccines is incomplete. 
Rates of protective immune response to vaccination are frequently low in vaccinated subjects, 
with worsened responses in older adults (Jefferson et al., 2010; Osterholm et al., 2012).  
Part of the poor vaccine efficacy in the elderly is due to immunosenescence (Haralambieva et 
al., 2015; Kennedy et al., 2016; Targonski et al., 2007) but molecular pathways associated 
with impaired vaccine responses remain incompletely understood. Identification of the 
mechanisms associated with the development of a protective immunity is of central 
importance in vaccinology, in order to improve our capacity to predict response to vaccination 
or develop potential interventions to improve the immune responses.  
To date, several studies have been conducted to identify genome-wide changes in 
transcriptional profiles that correlate with clinical response to influenza vaccination (Bucasas 
et al., 2011; Nakaya et al., 2011, 2015; Obermoser et al., 2013; Thakar et al., 2015; Tsang et 
al., 2014; Zhu et al., 2010), by assessing genome-wide gene expression with microarrays 
before and/or after vaccination of subjects. These molecular signatures, associated with better 
antibody responses, were frequently enriched in immune pathways, especially with type I 
interferon signaling, antigen presentation pathways or B-cell proliferation. Thakar et al. 
identified a dysregulation in this gene signature in older adults, specially in frail subjects who 
were non-responders to vaccination (Thakar et al., 2015). Other large-scale profiling studies 
have tried to identify further relevant biomarkers that could predict vaccine response: in this 
attempt, Furman et al. identified nine immunological baseline predictors of protective 
immunity, with two of these variables involved in apoptosis (Furman et al., 2013). Finally, 
models integrating and combining transcriptomic data with additional data types to predict 
response to vaccination have been developed recently (Tsang et al., 2014; Zimmermann et al., 
2017).  
While transcriptomic data have been deeply studied in this field, few reports have been 
published regarding epigenetic aspects. DNA methylation has an important role in several 
biological processes, especially in aging (Sen et al., 2016), and is therefore an interesting 
candidate to be investigated. Furthermore, DNA methylation measures tend to be more stable 
than transcriptomic data within the short period (days-weeks) and are more reproducible from 
a technical point of view. Lu et al. discovered two relevant epigenetic variations in poor-
responders to the vaccine directed against Hepatitis B virus (Lu et al., 2014). Concerning 
influenza vaccine, one recent study has identified numerous CpG sites showing associations 
with gene expression and other ones associated with the induction of the humoral immune 
response (Zimmermann et al., 2016).  
To complete these findings and evaluate the effect of age on vaccination response, here we 
investigated baseline (that is, immediately before vaccination) genome-wide DNA 
methylation in peripheral blood mononuclear cells (PBMC) from 44 healthy donors, ranging 
from 19 to 90 years, who received influenza vaccination and were classified as responders 
and non-responders according to hemagglutination inhibition assays (HIA) after 28 days. 
2. Materials and Methods 
2.1 Participants 
Participants (age range: 19 – 90 years) were recruited at the University of Miami Miller 
School of Medicine. Experiments were conducted using peripheral blood. Enrolled 
participants received the influenza vaccine in the pandemic season 2009 and in the season 
2010-2011. Participants enrolled in the pandemic 2009 season received the subunit vaccine 
containing the A/California/7/2009 (H1N1) strain, whereas those enrolled in the 2010-2011 
season received the Trivalent Inactivated influenza vaccine containing the following viral 
strains: A/California/7/2009 (H1N1), A/Perth/16/2009 (H3N2), B/Brisbane/60/2008. Whole 
blood samples were collected immediately before vaccination. PBMC were collected using 
Vacutainer CPT tubes (BD 362761). Cells were washed and cryopreserved. Appropriate 
signed informed consent was obtained from each subject prior to enrollment. The study was 
approved with IRB protocol #20070481. Each participant was asked questions regarding 
demographics, health behaviors, presence of symptoms associated with inflammatory 
conditions or respiratory infections at the time of enrollment. No one reported subclinical 
inflammatory conditions and/or had respiratory tract infections at the time of enrollment, nor 
was on any anti-inflammatory treatment or on medications known to alter the immune 
response. Participants were excluded if they had diseases known to alter the immune response.  
 
2.2 Assessment of response to vaccination 
Immunogenicity of influenza vaccine in subjects was assessed by hemagglutination inhibition 
assays (HIA). For this purpose, blood samples were collected immediately before vaccination 
(baseline) and 4-6 weeks after to evaluate the in vivo response and identify responders and 
non-responders. Responders had at least a 4-fold increase in the reciprocal of the titers in 
response to the whole vaccine, which was the A/California/7/2009 (H1N1) strain in the 2009 
season and the Trivalent Inactivated Influenza vaccine (containing A/California/7/2009 
(H1N1), A/Perth/16/2009 (H3N2), B/Brisbane/60/2008) in the 2010-2011 season. Briefly, 
sera were pretreated with receptor destroying enzyme (RDE, Denke Seiken Co Ltd) for 20 
hours at 37°C; in order to inactivate this enzyme, sera were then heated at 56°C for 60 
minutes. Two-fold serial dilutions were done; 25 µL of diluted sera were incubated with an 
equal volume of 4 HA units of the 2009 vaccine or of the 2010-2011 vaccine, for 1 hour at 
room temperature and then 50 µL of a 1.25 % suspension of chicken red blood cells were 
added. After 2 hours of incubation at room temperature titers were determined.  
 
2.3 Genome-wide DNA methylation analysis 
Genome-wide DNA methylation analysis was performed on PBMC collected immediately 
before vaccination (baseline) and cryopreserved. DNA methylation patterns are generally 
stable, highly reproducible and only slightly affected by freezing (Bulla et al., 2016). Total 
genomic DNA was extracted from PBMC using the AllPrep DNA/RNA Mini kit (Qiagen), 
according to manufacturer’s instructions. DNA concentrations were determined using 
NanoDrop spectrophotometer. DNA was bisulfite-converted using the EZ DNA Methylation 
Kit (Zymo Research Corporation®) and analyzed on the Infinium HumanMethylation450 
BeadChip (Illumina®) following manufacturer's instructions (Bibikova et al., 2011). Arrays 
were scanned by HiScan (Illumina®) and signal intensities were extracted from .idat files 
using the minfi Bioconductor package (Aryee et al., 2014). Data were normalized using the 
preprocessQuantile function of the package minfi. Probes on the X and Y chromosomes were 
removed, as well as probes associated to a SNP. Identification of CpG sites with differential 
methylation between responders and non-responders to influenza vaccination was performed 
through an analysis of variance (ANOVA) model, correcting for sex and batch. CpG sites 
differentially methylated between responders and non-responders were defined as having a 
nominal p-value inferior to 0.01 and an absolute difference between values of responders and 
non-responders of at least 0.05. Figures were generated using R. 
 
2.4 Epigenetic age estimation 
DNAm age, also referred to as epigenetic age, was calculated as described by Horvath 
(Horvath 2013), using the online age calculator freely available at the website: 
https://dnamage.genetics.ucla.edu. 
 
 
  
3. Results 
3.1 DNA methylation differences in responders and non-responders to influenza 
vaccination  
Forty-four subjects were included in the present study: 23 were responders to influenza 
vaccine, while 21 were considered as non-responders according to HIA assay. Characteristics 
of the subjects are summarized in Table 1.  
 
 
Table 1. Demographic characteristics of the subjects involved in the study. 
 
We used the Illumina® Infinium 450k microarray to generate genome wide DNA methylation 
data from PBMC collected pre-vaccination (baseline). As a first step in our analysis, we 
compared DNA methylation between responders and non-responders to influenza vaccination 
by ANOVA, correcting for age, sex and batch. No CpG sites withstood Benjamini-Hochberg 
false discovery rate correction for multiple testing (significant threshold: q-value <0.05). We 
then considered less stringent criteria (uncorrected p-value inferior to 0.01 and absolute 
difference between mean methylation values of responders and non-responders of at least 
0.05). In this way, we identified 83 differentially methylated CpG sites between the two 
groups of subjects, mapping in 52 annotated genes (Tables 2 and 3; Supplementary File 1), 
that were able to distinguish responders and non-responders in a multidimensional scaling 
(MDS) plot (Figure 1A). When looking at the genomic localization of these probes, we found 
3 genomic regions in which multiple adjacent CpG probes showed differential methylation 
between responders and non-responders: 3 probes mapped within the chr1:57110663-
57111337 island associated to PRKAA2 gene (Figure 1B), 2 mapped within the 
chr6:160209941-160212015 island associated to TCP1/MRPL18 genes and 2 mapped in 
TRAPPC9 gene, one in the chr8:141348840-141349195 island and one in the shore of the 
chr8:141467218-141467927 island. The presence of multiple differentially methylated probes 
within the same region indicates a general epigenetic remodeling of the genomic tract, which 
is likely to be biologically relevant (Bacalini et al., 2015; Wessely and Emes, 2012). 
 
 Number of differentially methylated CpG sites between responders and non-responders 
All subjects 83 
Young subjects (Age < 50 years) 142 
Old subjects (Age ≥ 50 years) 305 
 
Table 2. Number of differentially methylated CpG sites between responders and non-
responders to influenza vaccination, identified according to criteria described in Methods. 
 
 
N of subjects Sex N of subjects aged ≥ 50 years 
Age in the 
Young group 
(mean and sd) 
Age in the Old 
group (mean 
and sd) 
Responders 23 10M / 13F 11 28.4 (8.0) 64.1 (12.5) 
Non-responders 21 10M / 11F 12 33.4 (6.6) 63.2 (7.4) 
 
Table 3. Top 10 of the 83 differentially methylated CpG sites between responders (R) and 
non-responders (NR) to influenza vaccination. 
 
 
Figure 1: Comparison of DNA methylation profiles between responders (R) and non-
responders (NR) to influenza vaccination. (A) Multidimensional scaling plots of DNA 
methylation data of 83 differentially methylated CpG sites between R (green) and NR (red). 
(B) Line plot of mean methylation values +/- standard deviation in R (green) and NR (red) for 
each CpG site mapping in the CpG island chr1:57110663-57111337 (PRKAA2 gene). 
 
 
3.2 Age-associated epigenetic determinants of vaccination response  
In order to assess the effect of age on vaccination response, for each of the CpG probes 
identified as differentially methylated in the previous analysis we calculated the association 
with age, considering separately responders and non-responders to influenza vaccine 
Illumina 
ID Chromosome UCSC_RefGene_Name UCSC_CpG_Islands_Name Relation_to_UCSC_CpG_Island 
Uncorrected 
p-value 
Difference between 
mean methylation 
values of R and NR 
cg13235976 3  chr3:193858770-193859695 S_Shelf 3.04E-06 -0.0659 
cg01281776 4  chr4:20253276-20256868 Island 0.00016 -0.0562 
cg27559562 16 CLUAP1 chr16:3550773-3551274 N_Shore 0.00025 -0.0535 
cg19492632 19 SLC7A9 chr19:33350719-33350932 N_Shelf 0.00028 0.0637 
cg19497709 3 COPG chr3:128997382-128997600 N_Shelf 0.00057 -0.0544 
cg15219393 5 PPARGC1B chr5:149109570-149111750 Island 0.00062 0.0582 
cg05146089 5  chr5:926586-927401 Island 0.00068 -0.0507 
cg22385827 2 C2orf67 chr2:211035478-211036637 Island 0.00072 0.0501 
cg24845595 1 NTRK1; INSRR chr1:156814881-156815792 N_Shore 0.00073 -0.0513 
cg17177528 7  chr7:123672063-123673691 N_Shelf 0.00074 -0.0509 
(Supplementary Files 1 and 2). For some CpG probes, such as cg14987745 in TDG gene, 
methylation differences between responders and non-responders were not affected by age 
(Figure 2A). On the contrary, others CpG sites showed age-association specifically in one of 
the two groups. For example, the probe cg26923084 in the gene NID2 showed an age-
dependent decrease in methylation only in non-responders, with larger DNA methylation 
differences after the age of 50 years old (Figure 2B). 
 
 
Figure 2: Scatter plots of methylation values (y-axis) according to age of the subjects (x-axis) 
for the CpG probes in TDG (A) and NID2 (B) genes. Values indicate the pValue of the 
association between methylation and age in responders (R) (green) and non-responders (NR) 
(red) subjects. 
 
To better identify the epigenetic determinants of vaccine responsiveness that are dependent on 
the age of the subjects, we divided the cohort in two groups including younger (age < 50) and 
older (age ≥ 50) subjects. Within each subgroup, we compared DNA methylation between 
responders and non-responders, correcting for sex and batch. Also in this case, no CpG site 
survived the multiple test correction. Using the same selection criteria described above, in the 
Young group we identified 142 differentially methylated CpG sites, mapping in 98 annotated 
genes (Tables 2 and 4; Supplementary Files 3 and 4). Four loci had multiple differentially 
methylated probes: C5orf33 (2 CpG probes in the chr5:36241003-36242664 island), HCG4P6 
(3 CpG probes in the chr6:29894140-29895117 island and its shore), TRAF3 (2 CpG probes 
in the body of the gene) and RPTOR (4 CpG probes in the body of the gene, in the 
chr17:78863569-78863813 island and in the adjacent shore). In the Old subgroup, 305 CpG 
probes turned out to be differentially methylated, mapping in 206 genes (Tables 2 and 5; 
Supplementary Files 3 and 5). Eight loci contained multiple differentially methylated probes 
between old responders and non-responders: KIF5C (2 CpG probes, one in the 
chr2:149632682-149633882 island and one in the shore of chr2:149645536-149645834 
island), COL7A1 (2 CpG probes in the chr3:48631882-48632901 island), MIR886 (2 CpG 
probes in the chr3:48631882-48632901 island), TRAPPC9 (2 CpG probes, one in the 
chr8:141348840-141349195 island and one in the shore of chr8:141467218-141467927 
island), NKX2-3 (2 CpG probes in the chr10:101294443-101297263 island), MCF2L (2 CpG 
probes, one in the chr13:113687421-113687828 island and one in the shore of the 
chr13:113714784-113715160 island), MYOD (2 CpG probes, one in the shore of 
chr17:30822917-30823210 island and one in the chr17:30845903-30846702 island) and 
RGL3 (2 CpG probes, one in the chr19:11531278-11531590 island and one in its shore). No 
CpG probes were identified as differentially methylated both in the Young and in the Old 
group; however, when considering the genes in which the CpG probes map, COL7A1 and 
PAPLN turned out to be present in both the comparisons. For both the genes, the CpG probes 
identified as differentially methylated in the two comparisons mapped in near positions along 
the chromosome (within 1000 bp) and showed consistent age-dependent trends (for both the 
genes, and age-related hypomethylation specifically in the non-responders group), suggesting 
a general epigenetic remodeling of the two genomic regions.  
 
 
Table 4. Top 10 of the 142 differentially methylated CpG sites between responders (R) and 
non-responders (NR) to influenza vaccination (young subjects with age < 50 years). 
 
 
 
 
Illumina 
ID Chromosome UCSC_RefGene_Name UCSC_CpG_Islands_Name Relation_to_UCSC_CpG_Island 
Uncorrected 
p-value 
Difference between 
mean methylation 
values of R and NR 
cg21690945 4  chr4:170695989-170696274 S_Shelf 0.00011 -0.0520 
cg10420952 7 TWIST1 chr7:19156050-19158042 Island 0.00012 -0.0591 
cg25622597 3 RHOA; TCTA chr3:49448861-49449965 Island 0.00024 0.0626 
cg10033725 7 HEATR2 chr7:821689-822634 S_Shelf 0.00029 -0.0662 
cg24233211 6    0.00031 -0.1159 
cg07681156 19 ZNF581 chr19:56154791-56155117 Island 0.00038 -0.0551 
cg14562060 6 TCP11 chr6:35108801-35109499 Island 0.00040 -0.0553 
cg05696877 1 IFI44L   0.00046 0.0573 
cg23696891 6 TNFAIP3 chr6:138187825-138189141 Island 0.00052 -0.0631 
cg17014647 6 ATXN1   0.00067 0.0589 
 
Table 5. Top 10 of the 305 differentially methylated CpG sites between responders (R) and 
non-responders (NR) to influenza vaccination (old subjects with age ≥ 50 years). 
 
Finally, we investigated if the responsiveness to vaccination was associated to the epigenetic 
age of the subjects. In the last few years, DNA methylation-based biomarkers have gained 
particular relevance in the field of aging research and have been proposed as proxy of the 
biological age of an individual. The most popular epigenetic age estimator is Horvath’s 
epigenetic clock (Horvath, 2013) which has been shown to correlate with mortality (Chen et 
al., 2016; Christiansen et al., 2016; Marioni et al., 2015a; Perna et al., 2016), physical and 
cognitive fitness (Marioni et al., 2015b) and to detect a biological age-acceleration in frail 
subjects (Breitling et al., 2016). Frailty is of particular importance from our perspective, since 
it has been observed that this status impacts susceptibility to influenza and responsiveness to 
influenza vaccine (Yao et al., 2011). Here we used Horvath’s epigenetic clock to estimate the 
DNA methylation age (DNAmAge) in our cohort. Then for each individual, we calculated the 
delta between chronological age and DNAmAge, in order to detect deceleration (the subject is 
epigenetically younger than his/her chronological age) or acceleration effects (the subject is 
epigenetically older than his/her chronological age). No significant differences in delta values 
were observed between responders and non-responders, nor when we divided the cohort in the 
young and old subgroups (Figure 3). 
 
  
Illumina 
ID Chromosome UCSC_RefGene_Name UCSC_CpG_Islands_Name Relation_to_UCSC_CpG_Island 
Uncorrected 
p-value 
Difference between 
mean methylation 
values of R and NR 
cg14273502 12  chr12:113013099-113013529 Island 6.99E-05 -0.0575 
cg11644052 2 NFU1 chr2:69664291-69664816 S_Shore 0.00012 -0.0567 
cg26923084 14 NID2 chr14:52534581-52536722 S_Shore 0.00013 -0.0899 
cg23301925 14    0.00021 -0.0501 
cg22256027 4 MSX1 chr4:4864456-4864834 N_Shore 0.00024 0.0586 
cg13617280 12 SLC15A4; MGC16384   0.00029 0.0825 
cg24927800 2 DES chr2:220283200-220283750 Island 0.00031 -0.0710 
cg16956133 2  chr2:863930-865091 Island 0.00035 -0.0861 
cg21126344 17 SOX9 chr17:70116274-70119998 Island 0.00036 -0.0816 
cg10857729 8  chr8:976015-976416 N_Shelf 0.00043 0.0622 
 
 
Figure 3: Estimation of Horvath’s epigenetic clock in responders (R) and non-responders 
(NR) to influenza vaccination. (A) Scatter plot of DNAmAge (y axis) versus chronological 
age (x axis) in R and NR to influenza vaccination. (B) Boxplot of differences between 
DNAmAge and chronological age in R and NR. 
 
 
4. Discussion 
Understanding mechanisms associated with impaired vaccine responses is an important goal 
and this is particularly true in the context of aging. Age-associated alterations in immune 
responses, named immunosenescence, are in part responsible of the poor response after 
vaccination in elderly (Goronzy and Weyand, 2013). Role of DNA methylation in this 
phenomenon has been investigated in subjects aged 50 – 74 years old vaccinated against 
influenza. The authors identified multiples CpG sites associated with age and with strong 
correlations with immunosenescence markers (Kennedy et al., 2016), highlighting the 
possible implication of epigenetic regulation as an active mechanism that shapes the immune 
response during aging.  
In this study, we analyzed baseline whole genome DNA methylation profiles of 44 subjects 
ranging 19-90 years and receiving influenza vaccination. To the best of our knowledge, this is 
the first study to investigate methylation data in vaccinated subjects with such a wide range of 
ages, making it possible to identify age-related determinants of influenza vaccination 
response. Accordingly, we identified 83 differentially methylated probes when correcting for 
the age of the subjects, 142 in the young subgroup and 305 in the old subgroup. This suggests 
that DNA methylation differences between responders and non-responders are larger at older 
ages compared to younger ones. Non-responders did not show epigenetic age acceleration 
effects compared to responders, according to Horvath’s epigenetic clock.  
To our knowledge, none of the CpG sites we identified was previously found differentially 
methylated in studies investigating DNA methylation profiles in human vaccinology, and no 
significant enrichment in KEGG pathways was observed (data not shown). However, it is 
interesting that we identified differentially methylated probes mapping in genes that are 
involved in immunosenescence (CD40) (Metcalf et al., 2015; Toapanta and Ross, 2009) and 
in innate immunity responses during viral infection: CXCL16 (Piqueras et al., 2006), ULK1 
(Prantner et al., 2017), BCL11B (Yu et al., 2015), BTC (Al-Yahya et al., 2015). 
Senescence of the adaptive compartment of immunity, which is involved in the classic 
immunological memory (Crotty and Ahmed, 2004), has been widely studied and most of the 
cellular markers studied in the report published by Kennedy et al. are related to B or T 
lymphocytes (Kennedy et al., 2016). However, during last years, evidence has emerged that 
also innate immune cells have a sort of memory, called “trained immunity”. This 
phenomenon could be a contributor to the protective effects of vaccination, independently of 
T and B cells, mostly observed in bacteriological vaccines, such as BCG (Garly et al., 2003; 
Kleinnijenhuis et al., 2012; Tribouley et al., 1978; van ’t Wout et al., 1992). Whereas 
immunological memory associated to adaptive immunity relies upon genetic recombination 
and mutations for the development of antigen specific receptors, mechanistic studies have 
brought evidence that trained immunity does not involve these types of permanent genetic 
changes but is largely based on epigenetic remodeling in innate immune cells (such as 
myeloid cells (monocytes, macrophages), natural killer cells or innate lymphoid cells) (Netea 
et al., 2016). The epigenetic shift, mostly based on histone modifications but also on 
microRNAs and DNA methylation changes, follows modifications in cellular metabolism 
driven by the antigenic stimulation (Arts et al., 2016) and can shape the cellular response and 
remains over time. Identification of differentially methylated CpG sites between responders 
and non-responders after vaccination is an important step to gain knowledge on these 
processes, for the identification of genes that could be potential targets for functional analysis 
and for the development of new strategies of vaccination.  
 
In this study we analyzed total PBMC samples, like in most published system vaccinology 
studies which used whole blood or PBMC. One important advantage of this approach is that 
blood and PBMC can be easily obtained from individuals, but an important limit is the 
presence multiple diverse cell subsets. Indeed, the heterogeneity in cell populations in the 
analysis can possibly hide differences in DNA methylation patterns in individual cell types. 
Hoek et al. previously investigated the transcriptomic and proteomic profiles from PBMC and 
from sorted immune cells after influenza vaccination (T cells, B cells, natural killer cells, 
myeloid dendritic cells, monocytes and neutrophils). They described significantly different 
RNA and protein expression profiles between the groups (Hoek et al., 2015).  
Another possible limitation in our work is the lack of data regarding pre-existing immune 
status of the subjects that could affect vaccine response. It is known that older subjects are 
frequently non-responders to vaccine and that a 4-fold increase in HIA titers is more 
frequently found in young subjects as compared to old ones: in a meta-analysis, Goodwin et 
al. generated an adjusted odds-ratio of responses in elderly vs young adults of 0.24 to 0.59 in 
terms of seroconversion and seroprotection against 3 different influenza antigens (H1N1, 
H3N2 and B) (Goodwin et al., 2006). Weakened serological response to vaccination in elderly 
subjects are related to the effect of immunosenescence, but previous exposures to influenza 
antigens (via vaccinations or infections) have also an influence on the response to the new 
vaccination. In general, subjects with repeated previous influenza vaccinations and influenza 
specific antibodies at baseline have a reduced humoral response and so lower post-vaccination 
titers (Bucasas et al., 2011; Gulati et al., 2005; Huang et al., 2017; Ng et al., 2013; Sasaki et 
al., 2008; Thakar et al., 2015; Tsang et al., 2014). However, it has also recently been 
demonstrated in a study conducted on 136 young and 122 elderly individuals that young 
individuals respond better than elderly individuals to the first vaccination, but after 
subsequent vaccinations the difference in response between young and elderly individuals 
declines rapidly, suggesting that different prior vaccination history and/or infection histories 
must also be taken in consideration when influenza vaccination is examined (Mosterín 
Höpping et al., 2016). 
In this study, we evaluated the association of baseline DNA methylation patterns and response 
to the vaccination at different ages. Future studies should systematically evaluate the 
epigenetic response to influenza vaccination in subjects of different ages, analyzing DNA 
methylation and gene expression at different time points post-vaccination and correlating 
changes in epigenetic patterns with the antibody response. Although it has been demonstrated 
that vaccination does not profoundly alter DNA methylation profiles in PBMC (Zimmermann 
et al., 2016), further studies are necessary in this field, considering the impact of the age of 
the individuals and analyzing different cell types separately. Furthermore, DNA methylation 
signatures should be explored and validated in other independent datasets considering other 
influenza strains.  
 
5. Conclusion 
In conclusion, in this paper we identified possible age-related DNA methylation contributors 
to vaccine responsiveness. Further studies on larger independent cohorts are needed to define 
epigenetic biomarkers that can predict the vaccine efficacy. These models could be used to 
develop novel strategies to achieve optimal protective immune responses, specially in the 
elderly.  
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Figure Legends 
 
Figure 1: Comparison of DNA methylation profiles between responders (R) and non-
responders (NR) to influenza vaccination. (A) Multidimensional scaling plots of DNA 
methylation data of 83 differentially methylated CpG sites between R (green) and NR (red). 
(B) Line plot of mean methylation values +/- standard deviation in R (green) and NR (red) for 
each CpG site mapping in the CpG island chr1:57110663-57111337 (PRKAA2 gene). 
 
Figure 2: Scatter plots of methylation values (y-axis) according to age of the subjects (x-axis) 
for the CpG probes in TDG (A) and NID2 (B) genes. Values indicate the pValue of the 
association between methylation and age in responders (R) (green) and non-responders (NR) 
(red) subjects. 
 
Figure 3: Estimation of Horvath’s epigenetic clock in responders (R) and non-responders 
(NR) to influenza vaccination. (A) Scatter plot of DNAmAge (y axis) versus chronological 
age (x axis) in R and NR to influenza vaccination. (B) Boxplot of differences between 
DNAmAge and chronological age in R and NR. 
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Supplementary File 1: List of the differentially methylated CpG probes between responders 
(R) and non-responders (NR). 
 
Supplementary File 2: Scatter plots of methylation values (y-axis) according to age of the 
subjects (x-axis) for the 83 CpG probes identified as differentially methylated between 
responders (R) (green) and non-responders (NR) (red) subjects. Values indicate the p-values 
of the association between methylation and age in responders (R) (green) and non-responders 
(NR) (red) subjects. 
 
Supplementary File 3: Lists of the differentially methylated CpG probes between responders 
(R) and non-responders (NR) in young and old subjects. 
 
Supplementary File 4: Scatter plots of methylation values (y-axis) according to age of the 
subjects (x-axis) for the 142 CpG probes identified as differentially methylated between in 
responders (R) (green) and non-responders (NR) (red) subjects in the young subgroup. Values 
indicate the p-values of the association between methylation and age in responders (R) 
(green) and non-responders (NR) (red) subjects. 
 
Supplementary File 5: Scatter plots of methylation values (y-axis) according to age of the 
subjects (x-axis) for the 305 CpG probes identified as differentially methylated between in 
responders (R) (green) and non-responders (NR) (red) subjects in the old subgroup. Values 
indicate the p-values of the association between methylation and age in responders (R) 
(green) and non-responders (NR) (red) subjects. 
